Cardiac Computed Tomography: Characteristics of Isolated Left Ventricular Non-compaction
Overview
The diagnostic criteria for isolated left ventricular non-compaction cardiomyopathy (IVNC) have been well established for echocardiography and cardiac magnetic resonance, such validation is lacking for computed tomography (CT). Such criteria are of great clinical relevance as a growing number of patients undergo a cardiac CT scan in daily clinical routine. The investigators aim to test the diagnostic accuracy of cardiac CT in distinguishing IVNC from lesser degrees of trabecular layering seen in potential differential diagnoses such as cardiomyopathies and left ventricular hypertrophy or dilation. The investigators hypothesize that echocardiographic diagnosed pathological trabeculation can be distinguished by determining the ratio of non-compacted to compacted myocardium on cardiac CT.
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Prospective
- Study Primary Completion Date: December 2014
Arms, Groups and Cohorts
- IVNC
- differential diagnosis to IVNC
Participating in This Clinical Trial
Inclusion Criteria
- Established diagnosis of IVNC or differential diagnosis – Age: Men > 30 years, women > 50 years without menstruation for at least 2 month. – Written informed consent to participate Exclusion criteria:
Contraindication for cardiac CT
- Renal insufficiency (GFR < 60ml/min) – Known allergy to iodinated contrast agent – Known Hyperthyroidism – Non-sinus rhythm – Known premature ventricular or supraventricular beats – Hypotension (systolic blood pressure < 100mmHg) Contraindication for CMR – Implanted cardiac pacemaker or defibrillator – Other implanted medical devices (e.g. implantable cardioverter-defibrillator) – Claustrophobia – Known premature ventricular or supraventricular beats – Pregnancy – Claustrophobia
Gender Eligibility: All
Minimum Age: 30 Years
Maximum Age: 90 Years
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- University of Zurich
- Provider of Information About this Clinical Study
- Sponsor
- Overall Official(s)
- Felix Tanner, Prof. MD, Principal Investigator, University Hospital Zurich, Division of Cardiology
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.